Why VCs fell in love with pharma R&D in 2021
pharmaphorum
APRIL 5, 2022
The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind. And the search for a COVID-19 vaccine opened the industry’s eyes to the idea that innovation could happen quickly, and their processes needn’t be sacrosanct.
52 
Let's personalize your content